Obese children and myocardial deformation changes: some discrepancies but a large number of common points
We read with interest the article entitled 'Alterations of left ventricular myocardial strain in obese children' by Labombarda et al. 1 regarding the use of two-dimensional (2D) strain imaging to study whether severely overweight children show early abnormalities in myocardial function.
First of all we would like to point out that we published an article with a similar population and similar results 2 years ago. 2 We also would like to make some comments with the intention to help to understand the results. In our study, we used three-dimensional wall motion tracking (3D-WMT) technology (Artida system, Toshiba Medical Systems, Japan) instead of 2D speckle tracking technology. We found a decrease in left ventricular longitudinal and circumferential strains but an increase in radial strain, with a maintained left ventricular ejection fraction. As the authors say in the article, when using the 2D strain technology, 'radial strain is calculated perpendicularly at the longitudinal motion and is very influenced by the longitudinal out-of-plane motion, much more than the field of circumferential motion'. We think they are completely right as it is one of the main limitations of the 2D speckle tracking technology. 3 These studies also show that the radial strain remains an important challenge, with a lower accuracy than longitudinal and circumferential strains. For the case of apical acquisitions, as used in the study of Saltijeral et al., 2 speckle tracking in the radial direction, perpendicular to the beam, is hampered by lower spatial resolution and signal-to-noise ratio. Several possibilities exist for overcoming these limitations: (i) segmenting the endocardium and epicardium, the latter being difficult as this area is very heterogeneous and (ii) using the rule of incompressibility to deduce the radial strain from longitudinal and circumferential strains. In both cases it is necessary to be aware that the calculation of the radial strain remains an information to be taken with caution and that, in its current form, may not reflect a physiological reality.
Fractional flow reserve is a useful reference standard for myocardial perfusion studies with limitations I suggest an alternative conclusion based on the following reasoning: the initial 'validation' study 3 was really to determine the ischaemia threshold of FFR in patients with large and severe enough stress-induced ischaemic defects unequivocally detected by a known technique, stress SPECT/ ECHO. Once this was determined, FFR outperforms stress SPECT/ECHO in at least three scenarios, where it is currently useful clinically. First, the pressure wire can inherently accurately measure FFR in smaller vessels supplying smaller myocardial segments than in the initial validation study, below the detection limits of either stress SPECT/ECHO of high quality without artefact. Secondly, in patients susceptible to artefacts with either SPECT/ECHO, the accuracy of FFR remains unaffected. Thirdly, in balanced threevessel obstructive coronary artery disease (CAD) underestimated by SPECT because it measures intervessel relative flow reserve, the accuracy of FFR remains unaffected because it measures vessel-specific relative (to assumed maximal) flow reserve.
Therefore, it is not a tautology to use FFR as a reference standard in assessing accuracy of non-invasive studies including stress CMR/ SPECT/ECHO in other patient subgroups, after initial determination of the ischaemia threshold of FFR by stress SPECT/ECHO.
They list serial lesions in the same vessel as a limitation of FFR. Actually, FFR is uniquely able to determine the individual contributions of each of serial lesions by a careful pull back study to determine which lesion is significant and if stented both predict and confirm the improvement by repeat FFR post-stenting.
The real limitation of FFR as a reference standard is that its concordance for ischaemia with CFR (the basis of stress perfusion imaging) varies with the degree of the accompanying diffuse disease (DD) and microvascular dysfunction (MVD) in CAD patients by differentially affecting CFR and FFR, both decrease CFR, but DD decreases FFR and MVD increases FFR. Thus, the ischaemia threshold of FFR varies from 0.65 in a theoretical model without DD/MVD 4 to 0.75-0.8 in CAD patients. 3 The discordance between FFR and CFR by both invasive or non-invasive methods is 40% in CAD patients, 4 but in selected patients with single-vessel CAD presumably with mild DD/MVD, the concordance is much higher at r ¼ 0.87. 5 This can only be overcome by simultaneous measurement of coronary flow as with a hyperaemic stenosis resistance index.
The gold standard is a vessel-specific reliable absolute maximal myocardial blood flow measurement and positron emission tomography is the most developed today.
